The Procter & Gamble Company (PG) Cash Flow Statement
Where PG’s cash came from and went, FY2026
June 30, 2026 · U.S. dollars- Cash from operations
- $19.56B +9.8% vs FY2025
- Capital expenditures
- $4.41B 5.1% of revenue
- Free cash flow
- $15.15B 17.4% margin
- Returned to shareholders
- $15.26B 101% of free cash flow
- Change in cash
- $412.0M cash at year-end $9.97B
Drawn to scale: where the cash came from and how it was used. Hover for values.
PG operating cash flow, capex and free cash flow
PG cash flow trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | $12.75BFY2017 | $19.56BFY2026 | +4.9%/yr | |
| Capital expenditures | $3.38BFY2017 | $4.41BFY2026 | +3.0%/yr | |
| Free cash flow | $9.37BFY2017 | $15.15BFY2026 | +5.5%/yr | |
| Free cash flow margin | 14.4%FY2017 | 17.4%FY2026 | +3.0 pts | |
| Operating cash flow / net income | 0.83FY2017 | 1.21FY2026 | +0.38 | |
| Stock-based compensation | $366.0MFY2017 | $524.0MFY2026 | +4.1%/yr | |
| Dividends paid | $7.24BFY2017 | $10.23BFY2026 | +3.9%/yr | |
| Share buybacks (net) | $5.20BFY2017 | $5.03BFY2026 | −0.4%/yr | |
| Capex / revenue | 5.2%FY2017 | 5.1%FY2026 | −0.1 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
PG cash flow by activity
PG net income vs operating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
PG cash flow statement
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||
| Net income | $16.14B | $16.07B | $14.88B | $14.74B | $14.79B | $14.35B | $13.10B | $3.97B | $9.86B | $15.33B |
| Depreciation & amortization | $3.16B | $2.85B | $2.90B | $2.71B | $2.81B | $2.73B | $3.01B | $2.82B | $2.83B | $2.82B |
| Stock-based compensation | $524.0M | $476.0M | $562.0M | $545.0M | $528.0M | $540.0M | $558.0M | $515.0M | $395.0M | $366.0M |
| Change in working capital | $2.0M | −$2.47B | −$436.0M | −$1.22B | −$1.15B | $371.0M | $1.21B | $368.0M | $3.02B | −$443.0M |
| Other non-cash items | −$274.0M | $904.0M | $1.95B | $71.0M | −$258.0M | $373.0M | −$481.0M | $7.57B | −$1.24B | −$5.32B |
| Cash from operating activities | $19.56B | $17.82B | $19.85B | $16.85B | $16.72B | $18.37B | $17.40B | $15.24B | $14.87B | $12.75B |
| Investing activities | ||||||||||
| Capital expenditures | −$4.41B | −$3.77B | −$3.32B | −$3.06B | −$3.16B | −$2.79B | −$3.07B | −$3.35B | −$3.72B | −$3.38B |
| Investments (net) | — | −$3.82B | −$3.50B | −$3.50B | $3.0M | −$55.0M | $3.04B | $3.41B | $46.0M | −$3.38B |
| Acquisitions & other investing | −$215.0M | $3.77B | $3.32B | $3.06B | −$1.27B | $8.0M | $3.07B | −$3.55B | $160.0M | $80.0M |
| Cash from investing activities | −$4.62B | −$3.82B | −$3.50B | −$3.50B | −$4.42B | −$2.83B | $3.04B | −$3.49B | −$3.51B | −$6.68B |
| Financing activities | ||||||||||
| Dividends paid | −$10.23B | −$9.87B | −$9.31B | −$9.00B | −$8.77B | −$8.26B | −$7.79B | −$7.50B | −$7.31B | −$7.24B |
| Share repurchases & issuance (net) | −$5.03B | −$6.50B | −$5.01B | −$7.35B | −$10.00B | −$11.01B | −$7.41B | −$5.00B | −$7.00B | −$5.20B |
| Net borrowing (repayment) | −$107.0M | $630.0M | −$2.44B | $2.94B | $1.89B | −$3.90B | $4.85B | −$817.0M | −$1.24B | $1.40B |
| Shares issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other financing | $166.0M | $1.71B | $1.91B | $1.27B | $2.00B | $1.64B | $1.98B | $3.32B | $1.18B | $2.47B |
| Cash from financing activities | −$15.20B | −$14.04B | −$14.86B | −$12.15B | −$14.88B | −$21.53B | −$8.37B | −$9.99B | −$14.38B | −$8.57B |
| Summary | ||||||||||
| Net change in cash | $412.0M | $74.0M | $1.24B | $1.03B | −$3.07B | −$5.89B | $11.94B | $1.67B | −$3.00B | −$1.53B |
| Cash at end of period | $9.97B | $9.56B | $9.48B | $8.25B | $7.21B | $10.29B | $16.18B | $4.24B | $2.57B | $5.57B |
| Free cash flow | $15.15B | $14.04B | $16.52B | $13.79B | $13.57B | $15.58B | $14.33B | $11.89B | $11.15B | $9.37B |
| Free cash flow margin | 17.4% | 16.7% | 19.7% | 16.8% | 16.9% | 20.5% | 20.2% | 17.6% | 16.7% | 14.4% |
| Capex / revenue | 5.1% | 4.5% | 4.0% | 3.7% | 3.9% | 3.7% | 4.3% | 4.9% | 5.6% | 5.2% |
| Operating cash flow / net income | 1.21 | 1.11 | 1.33 | 1.14 | 1.13 | 1.28 | 1.33 | 3.84 | 1.51 | 0.83 |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||
| Net income | $3.08B | $3.95B | $4.33B | $4.78B | $3.63B | $3.79B | $4.66B | $3.99B | $3.14B | $3.75B | $3.47B | $4.56B |
| Depreciation & amortization | $812.0M | $785.0M | $802.0M | $761.0M | $723.0M | $690.0M | $706.0M | $728.0M | $761.0M | $712.0M | $721.0M | $702.0M |
| Stock-based compensation | $130.0M | $132.0M | $141.0M | $121.0M | $112.0M | $123.0M | $136.0M | $105.0M | $129.0M | $158.0M | $150.0M | $125.0M |
| Change in working capital | $462.0M | −$460.0M | $304.0M | −$304.0M | $2.46B | −$942.0M | $1.50B | −$1.50B | $1.44B | −$606.0M | −$487.0M | −$786.0M |
| Other non-cash items | $646.0M | −$363.0M | −$606.0M | $49.0M | −$1.93B | $41.0M | −$2.17B | $978.0M | $284.0M | $1.31B | $1.25B | $307.0M |
| Cash from operating activities | $5.13B | $4.04B | $4.97B | $5.41B | $4.99B | $3.71B | $4.83B | $4.30B | $5.75B | $5.33B | $5.10B | $4.90B |
| Investing activities | ||||||||||||
| Capital expenditures | −$1.02B | −$1.02B | −$1.17B | −$1.20B | −$996.0M | −$859.0M | −$925.0M | −$993.0M | −$783.0M | −$797.0M | −$817.0M | −$925.0M |
| Investments (net) | — | — | — | −$1.53B | −$1.06B | −$726.0M | −$921.0M | −$1.11B | −$518.0M | −$762.0M | −$1.00B | −$1.22B |
| Acquisitions & other investing | −$173.0M | $354.0M | −$61.0M | $1.20B | $996.0M | $859.0M | $925.0M | $993.0M | $783.0M | −$448.0M | $817.0M | $925.0M |
| Cash from investing activities | −$1.20B | −$665.0M | −$1.23B | −$1.53B | −$1.06B | −$726.0M | −$921.0M | −$1.11B | −$518.0M | −$2.01B | −$1.00B | −$1.22B |
| Financing activities | ||||||||||||
| Dividends paid | −$2.61B | −$2.53B | −$2.54B | −$2.55B | −$2.55B | −$2.43B | −$2.44B | −$2.44B | −$2.45B | −$2.29B | −$2.29B | −$2.29B |
| Share repurchases & issuance (net) | −$875.0M | −$625.0M | −$2.28B | −$1.25B | −$700.0M | −$1.35B | −$2.51B | −$1.94B | −$1.52B | −$987.0M | −$1.00B | −$1.50B |
| Net borrowing (repayment) | −$2.86B | $665.0M | $658.0M | $1.43B | −$468.0M | −$1.05B | −$859.0M | $3.00B | — | — | — | $1.44B |
| Shares issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other financing | −$705.0M | $663.0M | $76.0M | $132.0M | $105.0M | $617.0M | $239.0M | $745.0M | $1.47B | −$997.0M | −$2.76B | $311.0M |
| Cash from financing activities | −$7.05B | −$1.83B | −$4.09B | −$2.24B | −$3.62B | −$4.21B | −$5.57B | −$634.0M | −$2.50B | −$4.27B | −$6.05B | −$2.04B |
| Summary | ||||||||||||
| Net change in cash | −$2.34B | $1.48B | −$346.0M | $1.61B | $440.0M | −$1.11B | −$1.93B | $2.67B | $2.65B | −$1.06B | −$1.84B | $1.49B |
| Cash at end of period | $9.97B | $12.31B | $10.82B | $11.17B | $9.56B | $9.12B | $10.23B | $12.16B | $9.48B | $6.83B | $7.89B | $9.73B |
| Free cash flow | $4.11B | $3.03B | $3.81B | $4.21B | $3.99B | $2.85B | $3.90B | $3.31B | $4.97B | $4.54B | $4.28B | $3.98B |
| Free cash flow margin | 19.4% | 14.3% | 17.1% | 18.8% | 19.1% | 14.4% | 17.8% | 15.2% | 24.2% | 22.5% | 20.0% | 18.2% |
| Capex / revenue | 4.8% | 4.8% | 5.3% | 5.4% | 4.8% | 4.3% | 4.2% | 4.6% | 3.8% | 3.9% | 3.8% | 4.2% |
| Operating cash flow / net income | 1.67 | 1.02 | 1.15 | 1.13 | 1.37 | 0.98 | 1.04 | 1.08 | 1.83 | 1.42 | 1.47 | 1.08 |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
PG cash generation
In fiscal 2026 (ended June 30, 2026), Procter & Gamble generated $19.6 billion of cash from operations (up 9.8%) and spent $4.4 billion on capital expenditures, leaving free cash flow of $15.1 billion, 17.4% of revenue. It returned $15.3 billion to shareholders through dividends ($10.2 billion) and net share buybacks ($5.0 billion). Cash and equivalents rose by $412.0 million over the year.
Related: PG income statement, PG balance sheet, PG dividend history. See the PG stock overview for the latest quote and news.
PG cash flow FAQ
What is Procter & Gamble's free cash flow?
Procter & Gamble's free cash flow was $15.1 billion in fiscal 2026: $19.6 billion of operating cash flow minus $4.4 billion of capital expenditures It was $14.0 billion a year earlier..
How much cash does Procter & Gamble generate from operations?
Procter & Gamble generated $19.6 billion of cash from operating activities in fiscal 2026, 1.21 times its net income of $16.1 billion.
How much does Procter & Gamble spend on capital expenditures?
Procter & Gamble spent $4.4 billion on capital expenditures in fiscal 2026, 5.1% of revenue, compared with $3.8 billion the year before.
How much stock does Procter & Gamble buy back?
Procter & Gamble spent $5.0 billion on net share repurchases in fiscal 2026.
How much does Procter & Gamble pay in dividends?
Procter & Gamble paid $10.2 billion in dividends in fiscal 2026, 67.6% of free cash flow.